Sort   by:  
 Page size 
UnknownA methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function.
Not available
S-EPMC12034072 | biostudies-literature
UnknownClinical impact of genomic testing in patients with suspected monogenic kidney disease.
Not available
S-EPMC7790755 | biostudies-literature
UnknownIntegrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice.
Not available
S-EPMC12034076 | biostudies-literature
UnknownAustralian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare.
Not available
S-EPMC10027474 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538 | biostudies-literature
UnknownAspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213 | biostudies-literature
UnknownHigher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownTherapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
Not available
S-EPMC8362592 | biostudies-literature
Sort   by:  
 Page size